Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance

BACKGROUND: Osteosarcoma is the most common bone malignancy in children and adolescents, and 20%–30% of the patients suffer from poor prognosis because of individual chemoresistance. The Hippo/yes-associated protein (YAP) signaling pathway has been shown to play a role in tumor chemoresistance, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong-Yu, Wu, Ya-Nan, Huang, Jun-Qi, Wang, Wei, Xu, Meng, Jia, Jin-Peng, Han, Gang, Mao, Bei-Bei, Bi, Wen-Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875723/
https://www.ncbi.nlm.nih.gov/pubmed/27206784
http://dx.doi.org/10.1186/s40880-016-0109-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875723/
https://www.ncbi.nlm.nih.gov/pubmed/27206784
http://dx.doi.org/10.1186/s40880-016-0109-z

Ejemplares similares